Alnylam Pharmaceuticals Inc financials at a glance
| Year | Year | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$4.28M | $5.72M | $26.93M | $50.90M | $96.16M | $100.53M | $100.04M | $82.76M | $66.73M | $47.17M | $50.56M | $41.10M | $47.16M | $89.91M | $74.91M | $219.75M | $492.85M | $844.29M | $1.04B | $1.83B | $0.00M |
| GM % | Gross Margin % |
|
100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 97.59% | 88.60% | 84.16% | 83.40% | 83.73% | 83.02% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | -146.68% | -183.07% | -28.95% | -47.86% | -41.86% | -66.24% | -91.04% | -197.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -168.09% | -83.93% | -75.68% | -15.43% | 0.00% |
| EPS | Earnings Per Share |
|
$-1.74 | $-1.09 | $-2.21 | $-0.64 | $-1.14 | $-1.04 | $-1.35 | $-2.11 | $-1.45 | $-1.88 | $-3.45 | $-4.79 | $-5.42 | $-6.21 | $-6.70 | $-6.38 | $-6.14 | $-6.50 | $-1.72 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | -0.00% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0 |
| Sha. | Shares |
|
20.09m | 26.63m | 37m | 40.7m | 41.41m | 41.82m | 42.2m | 42.73m | 52.41m | 63.43m | 76.93m | 84.74m | 85.81m | 99.17m | 101.03m | 111.49m | 116.18m | -5470.25m | 119.6m | 0m | 125.49m |
| OCF | Operating Cash Flow |
|
$-19.57M | $-16.49M | $-24.63M | $196.52M | $65.49M | $-72.15M | $-84.34M | $-87.07M | $-115.61M | $-68.66M | $-165.64M | $-189.14M | $-307.70M | $-382.79M | $-562.62M | $-278.43M | $-614.96M | $-641.69M | $-541.27M | $0.00M | $0.00M |
| FCF | Free Cash Flow |
|
$-28.58M | $-18.44M | $-29.62M | $188.73M | $54.73M | $-77.10M | $-89.07M | $-88.90M | $-123.96M | $-72.66M | $-174.60M | $-202.09M | $-372.26M | $-487.00M | $-689.50M | $-418.58M | $-685.32M | $-718.07M | $-613.33M | $-97.12M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-2.40 | $-0.84 | $-0.93 | $4.88 | $1.33 | $-1.85 | $-2.12 | $-2.08 | $-2.47 | $-1.18 | $-2.35 | $-2.41 | $-4.35 | $-5.38 | $-6.85 | $-3.83 | $-5.96 | $-6.06 | $-5.04 | $0.00 | $0.00 |